Results 1 to 10 of about 22,605 (225)
Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa [PDF]
Infectious Agents and Cancer, 2011 Background Kaposi sarcoma (KS) is the most common AIDS-defining tumour in HIV-infected individuals in Africa. Kaposi sarcoma herpes virus (KSHV) infection precedes development of KS.
Maskew Mhairi +5 more
doaj +4 more sources
Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection [PDF]
Cell & Bioscience, 2021 Kaposi’s sarcoma-associated herpesvirus (KSHV) is an oncogenic gammaherpesvirus associated with several human cancers. KSHV infection and KSHV-induced anabolic cell proliferation and cellular transformation depend on reprogramming of cellular metabolic ...
Tingting Li, Shou-Jiang Gao
doaj +3 more sources
DNA-Packing Portal and Capsid-Associated Tegument Complexes in the Tumor Herpesvirus KSHV [PDF]
Cell, 2019 Assembly of Kaposi's sarcoma-associated herpesvirus (KSHV) begins at a bacteriophage-like portal complex that nucleates formation of an icosahedral capsid with capsid-associated tegument complexes (CATCs) and facilitates translocation of an ∼150-kb dsDNA
Danyang Gong, Xinghong Dai, Jonathan Jih
exaly +3 more sources
Viruses, 2021 Kaposi sarcoma-associated herpesvirus (KSHV) is the causative agent of multiple cancers in immunocompromised patients including two lymphoproliferative disorders associated with KSHV infection of B lymphocytes.
Nancy Palmerin +5 more
doaj +1 more source
Investigation of CDH1 germline mutations in Turkish patients with Kaposi’s sarcoma
Türk Biyokimya Dergisi, 2022 Kaposi’s sarcoma (KS) develops from the lining cells of blood or lymphatic vessels and may appear as red, purple, brown, or black lesions. E-cadherin, CDH1, is a cell adhesion molecule located on the surface of epithelial cells.
Celik Betul, Tuncer Seref Bugra
doaj +1 more source
Viruses, 2020 Kaposi’s sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi’s sarcoma (KS), one of the most prevalent cancers of people living with HIV/AIDS in sub-Saharan Africa.
Yasaman Mortazavi +5 more
doaj +1 more source
Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection. [PDF]
PLoS Pathogens, 2009 Since Kaposi's sarcoma-associated herpesvirus (KSHV or human herpesvirus 8) was first identified in Kaposi's sarcoma (KS) lesions of HIV-infected individuals with AIDS, the basic biological understanding of KSHV has progressed remarkably.
Heesoon Chang +8 more
doaj +1 more source
Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) – review
Romanian Journal of Internal Medicine, 2020 Human herpesvirus 8 (HHV8), also known as Kaposi sarcoma-associated herpesvirus (KSHV), is one of the few pathogens recognized as direct carcinogen, being involved in the pathogenesis of Kaposi sarcoma, primary effusion lymphoma and multicentric ...
Iftode Nicoleta +3 more
doaj +1 more source
Frontiers in Microbiology, 2021 Kaposi’s sarcoma-associated herpesvirus (KSHV) is the most common cause of Kaposi’s sarcoma (KS) and other malignant growths in humans. However, the lack of a KSHV-infected small animal model has hampered understanding of the mechanisms of KSHV infection,
Daoqun Li +9 more
doaj +1 more source
Frontiers in Immunology, 2022 IntroductionFactors influencing Kaposi’s sarcoma-associated herpesvirus (KSHV) transmission and the early stages of KSHV infection in the human immune system remain poorly characterized.
Nedaa Alomari, Jennifer Totonchy
doaj +1 more source